Partial splenic embolization facilitates completion of interferon therapy in patients with chronic HCV infection and hypersplenism.
Kato
Masaki
M
Shimohashi
Naoya
N
Ouchi
Jiro
J
Yoshida
Kisaku
K
Tanabe
Yuichi
Y
Takenaka
Kenji
K
Nakamuta
Makoto
M
D000998:Antiviral Agents / Q000627:therapeutic use*; D001772:Blood Cell Count; D004621:Embolization, Therapeutic; D005260:Female; D019698:Hepatitis C, Chronic / Q000097:blood / Q000150:complications / Q000628:therapy*; D006801:Humans; D006971:Hypersplenism / Q000150:complications / Q000628:therapy*; D007155:Immunologic Factors / Q000627:therapeutic use*; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D013157:Splenic Artery
D000998:Antiviral Agents; D007155:Immunologic Factors; D016898:Interferon-alpha